Glen Eagle Advisors, LLC Merck & Co., Inc. Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 8,517 shares of MRK stock, worth $1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
8,517
Previous 5,506
54.69%
Holding current value
$1 Million
Previous $300 Million
251.56%
% of portfolio
0.19%
Previous 0.25%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,825Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$28.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$24.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.8 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.54 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.72 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $299B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...